Trastuzumab-induced cardiotoxicity and its risk factors in real-world setting of breast cancer patients

Overview of attention for article published in Journal of Cancer Research and Clinical Oncology, June 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 37 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Lisinopril and carvedilol reduce cardiotoxicity in breast cancer patients receiving trastuzumab and anthracyclines

2 Minute Medicine , 15 Jun 2019

1. In this randomized, placebo controlled study of HER2-positive breast cancer patients receiving trastuzumab, use of…